Coastal Bridge Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.61M Buy
5,300
+83
+2% +$45K 0.18% 130
2025
Q4
$3.02M Sell
5,217
-283
-5% -$160K 0.23% 107
2025
Q3
$2.67M Buy
5,500
+1,719
+45% +$800K 0.2% 117
2025
Q2
$1.53M Sell
3,781
-665
-15% -$278K 0.13% 163
2025
Q1
$2.21M Buy
+4,446
New +$2.41M 0.55% 46
2024
Q4
Sell
-646
Closed -$400K 176
2024
Q3
$400K Sell
646
-8
-1% -$4.74K 0.1% 104
2024
Q2
$362K Buy
654
+8
+1% +$4.58K 0.09% 109
2024
Q1
$375K Hold
646
0.09% 108
2023
Q4
$343K Buy
646
+7
+1% +$3.39K 0.09% 113
2023
Q3
$323K Hold
639
0.09% 113
2023
Q2
$333K Buy
639
+5
+0.8% +$2.7K 0.08% 112
2023
Q1
$365K Hold
634
0.09% 106
2022
Q4
$349K Sell
634
-32
-5% -$17K 0.1% 107
2022
Q3
$338K Buy
666
+32
+5% +$17.9K 0.09% 109
2022
Q2
$344K Buy
634
+30
+5% +$16.5K 0.11% 104
2022
Q1
$357K Buy
+604
New +$347K 0.08% 103

Other funds holding TMO

Coastal Bridge Advisors's TMO Position: Q1 2026 in Review

Coastal Bridge Advisors increased its Thermo Fisher Scientific (TMO) stake by 1.6% in Q1 2026, buying an estimated $45K and bringing the position to 5,300 shares worth $2.61M. The position accounts for 0.18% of the portfolio, ranked #130.

Coastal Bridge Advisors first reported a position in TMO in Q1 2022 and has held it in 16 quarters since. The position peaked at $3.02M in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Coastal Bridge Advisors held 5,300 shares of Thermo Fisher Scientific worth $2.61M as of Q1 2026.
  • Coastal Bridge Advisors bought 83 Thermo Fisher Scientific shares in Q1 2026, an estimated $45K.
  • Thermo Fisher Scientific made up 0.18% of Coastal Bridge Advisors's portfolio in Q1 2026, its #130 holding.
  • Coastal Bridge Advisors first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 16 quarters since.
  • Coastal Bridge Advisors's Thermo Fisher Scientific position peaked at $3.02M in Q4 2025.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Coastal Bridge Advisors's 13F filing for Q1 2026, filed 14 May 2026.